Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
09/29/2023 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 1.4k | $27.08 | $37.5k | | 09/29/2023 |
08/21/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 853 | $829.00 | $707.1k | | 08/21/2023 |
08/21/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 853 | $391.92 | $334.3k | | 08/21/2023 |
08/10/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 853 | $789.00 | $673k | | 08/10/2023 |
08/10/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 853 | $391.92 | $334.3k | | 08/10/2023 |
06/30/2023 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 1.2k | $31.03 | $37.5k | | 06/30/2023 |
03/31/2023 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 1k | $35.73 | $37.5k | | 03/31/2023 |
03/24/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1.2k | $818.00 | $1M | | 03/24/2023 |
03/24/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 1.2k | $380.95 | $472.4k | | 03/24/2023 |
02/03/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1k | $779.00 | $795.4k | | 02/03/2023 |
02/03/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 1k | $380.95 | $388.9k | | 02/03/2023 |
01/03/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Grant | Common Stock | 165 | $0.00 | $0 | | 01/03/2023 |
01/03/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Grant | Non-Qualified Stock Option (right to buy) | 1.9k | $725.89 | $1.4M | | 01/03/2023 |
12/30/2022 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 943 | $39.76 | $37.5k | | 12/30/2022 |
12/08/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 218 | $779.00 | $169.8k | | 12/08/2022 |
12/08/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 218 | $380.95 | $83k | | 12/08/2022 |
09/30/2022 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 913 | $41.06 | $37.5k | | 09/30/2022 |
09/09/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 609 | $741.00 | $451.3k | | 09/08/2022 |
09/09/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 609 | $376.69 | $229.4k | | 09/08/2022 |
09/08/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 1.3k | $391.92 | $501.3k | | 09/08/2022 |
09/08/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1.3k | $705.00 | $901.7k | | 09/08/2022 |
09/08/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1.3k | $686.99 | $878.7k | | 09/08/2022 |
06/30/2022 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 903 | $41.52 | $37.5k | | 06/30/2022 |
06/24/2022 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 6.3k | $0.00 | $0 | | 06/24/2022 |
06/22/2022 | Cidara Therapeutics, Inc. | CDTX | Grant | Stock Option (right to buy) | 28k | $0.53 | $14.8k | | 06/22/2022 |
04/07/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 1.2k | $380.95 | $472.4k | | 04/07/2022 |
04/07/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1.2k | $725.00 | $899k | | 04/07/2022 |
03/31/2022 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 964 | $38.87 | $37.5k | | 03/31/2022 |
03/30/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1.2k | $700.00 | $868k | | 03/30/2022 |
03/30/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 1.2k | $380.95 | $472.4k | | 03/30/2022 |
01/03/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Grant | Common Stock | 191 | $0.00 | $0 | | 01/03/2022 |
01/03/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Grant | Non-Qualified Stock Option (right to buy) | 2.7k | $625.60 | $1.7M | | 01/03/2022 |
12/31/2021 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 958 | $39.11 | $37.5k | | 12/31/2021 |
09/30/2021 | Royalty Pharma plc | RPRX | Grant | Class A Ordinary Shares | 992 | $37.80 | $37.5k | | 09/30/2021 |
08/05/2021 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 2.6k | $600.00 | $1.5M | | 08/05/2021 |
|